These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34226219)

  • 1. Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19.
    Kjellberg A; Douglas J; Pawlik MT; Kraus M; Oscarsson N; Zheng X; Bergman P; Frånberg O; Kowalski JH; Nyren SP; Silvanius M; Skold M; Catrina SB; Rodriguez-Wallberg KA; Lindholm P
    BMJ Open; 2021 Jul; 11(7):e046738. PubMed ID: 34226219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial.
    Kjellberg A; Abdel-Halim L; Hassler A; El Gharbi S; Al-Ezerjawi S; Boström E; Sundberg CJ; Pernow J; Medson K; Kowalski JH; Rodriguez-Wallberg KA; Zheng X; Catrina S; Runold M; Ståhlberg M; Bruchfeld J; Nygren-Bonnier M; Lindholm P
    BMJ Open; 2022 Nov; 12(11):e061870. PubMed ID: 36323462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".
    Tornero C; Vallejo R; Cedeño D; Orduña J; Pastor E; Belaouchi M; Escamilla B; Laredo M; Del Mar Garzando M
    Trials; 2020 Jun; 21(1):576. PubMed ID: 32586395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five sessions of hyperbaric oxygen for critically ill patients with COVID-19-induced ARDS: A randomised, open label, phase II trial.
    Kjellberg A; Douglas J; Pawlik MT; Hassler A; Al-Ezerjawi S; Boström E; Abdel-Halim L; Liwenborg L; Jonasdottir-Njåstad AD; Kowalski J; Catrina SB; Rodriguez-Wallberg KA; Lindholm P
    Respir Med; 2024 Oct; 232():107744. PubMed ID: 39059726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
    Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
    Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19-Induced Acute Respiratory Distress Syndrome Treated with Hyperbaric Oxygen: Interim Safety Report from a Randomized Clinical Trial (COVID-19-HBO).
    Kjellberg A; Douglas J; Hassler A; Al-Ezerjawi S; Boström E; Abdel-Halim L; Liwenborg L; Hetting E; Jonasdottir Njåstad AD; Kowalski J; Catrina SB; Rodriguez-Wallberg KA; Lindholm P
    J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The outcomes of COVID-19 measures in a hyperbaric oxygen therapy centre during the pandemic.
    Ozgok-Kangal K; Zaman T; Koc B
    Int Marit Health; 2021; 72(3):228-236. PubMed ID: 34604994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors associated with day-30 mortality in patients over 60 years old admitted in ICU for severe COVID-19: the Senior-COVID-Rea Multicentre Survey protocol.
    Falandry C; Malapert A; Roche M; Subtil F; Berthiller J; Boin C; Dubreuil J; Ravot C; Bitker L; Abraham P; Collange V; Balança B; Goutte S; Guichon C; Gadea E; Argaud L; Dayde D; Jallades L; Lepape A; Pialat JB; Friggeri A; Thiollière F;
    BMJ Open; 2021 Jul; 11(7):e044449. PubMed ID: 34230013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virtual reality for relatives of ICU patients to improve psychological sequelae: study protocol for a multicentre, randomised controlled trial.
    Vlake JH; van Bommel J; Wils EJ; Korevaar T; Hellemons ME; Klijn E; Schut AF; Labout JA; Van Bavel MP; van Mol MM; Gommers D; van Genderen ME
    BMJ Open; 2021 Sep; 11(9):e049704. PubMed ID: 34588250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological and outcome analysis of COVID-19-associated pneumothorax: multicentre retrospective critical care experience from Qatar.
    Akram J; Yousaf Z; Alabbas Y; Almoyaaf MIA; Ibrahim ASS; Kharma N
    BMJ Open; 2022 Feb; 12(2):e053398. PubMed ID: 35190427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of early low-calorie low-protein versus standard-calorie standard-protein feeding on outcomes of ventilated adults with shock: design and conduct of a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3).
    Reignier J; Le Gouge A; Lascarrou JB; Annane D; Argaud L; Hourmant Y; Asfar P; Badie J; Nay MA; Botoc NV; Brisard L; Bui HN; Chatellier D; Chauvelot L; Combes A; Cracco C; Darmon M; Das V; Debarre M; Delbove A; Devaquet J; Voicu S; Aissaoui-Balanant N; Dumont LM; Oziel J; Gontier O; Groyer S; Guidet B; Jaber S; Lambiotte F; Leroy C; Letocart P; Madeux B; Maizel J; Martinet O; Martino F; Mercier E; Mira JP; Nseir S; Picard W; Piton G; Plantefeve G; Quenot JP; Renault A; Guérin L; Richecoeur J; Rigaud JP; Schneider F; Silva D; Sirodot M; Souweine B; Reizine F; Tamion F; Terzi N; Thévenin D; Thiéry G; Thieulot-Rolin N; Timsit JF; Tinturier F; Tirot P; Vanderlinden T; Vinatier I; Vinsonneau C; Maugars D; Giraudeau B
    BMJ Open; 2021 May; 11(5):e045041. PubMed ID: 33980526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TELE-critical Care verSus usual Care On ICU PErformance (TELESCOPE): protocol for a cluster-randomised clinical trial on adult general ICUs in Brazil.
    Noritomi DT; Ranzani OT; Ferraz LJR; Dos Santos MC; Cordioli E; Albaladejo R; Serpa Neto A; Correa TD; Berwanger O; de Morais LC; Schettino G; Cavalcanti AB; Rosa RG; Biondi RS; Salluh JI; Azevedo LCP; Pereira AJ;
    BMJ Open; 2021 Jun; 11(6):e042302. PubMed ID: 34155070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)-protocol of randomised controlled trial AZIQUINE-ICU.
    Duška F; Waldauf P; Halačová M; Zvoníček V; Bala J; Balík M; Beneš J; Klementová O; Kozáková I; Kubricht V; Le Roy A; Vymazal T; Řehořová V; Černý V;
    Trials; 2020 Jul; 21(1):631. PubMed ID: 32641163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units.
    Voiriot G; Fartoukh M; Durand-Zaleski I; Berard L; Rousseau A; Armand-Lefevre L; Verdet C; Argaud L; Klouche K; Megarbane B; Patrier J; Richard JC; Reignier J; Schwebel C; Souweine B; Tandjaoui-Lambiotte Y; Simon T; Timsit JF;
    BMJ Open; 2021 Aug; 11(8):e048187. PubMed ID: 34408046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxycycline for the prevention of progression of COVID-19 to severe disease requiring intensive care unit (ICU) admission: A randomized, controlled, open-label, parallel group trial (DOXPREVENT.ICU).
    Dhar R; Kirkpatrick J; Gilbert L; Khanna A; Modi MM; Chawla RK; Dalal S; Maturu VN; Stern M; Keppler OT; Djukanovic R; Gadola SD
    PLoS One; 2023; 18(1):e0280745. PubMed ID: 36689456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled Nitric Oxide ReDuce postoperatIve pulmoNAry complicaTions in patiEnts with recent COVID-19 infection (INORDINATE): protocol for a randomised controlled trial.
    Zheng Z; Wang L; Wang S; Fan Q; Zhang H; Luo G; Gao B; Yang X; Zhao B; Wang X; Dong H; Nie H; Lei C
    BMJ Open; 2024 Mar; 14(3):e077572. PubMed ID: 38485487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperbaric oxygen as an adjuvant treatment for patients with COVID-19 severe hypoxaemia: a randomised controlled trial.
    Cannellotto M; Duarte M; Keller G; Larrea R; Cunto E; Chediack V; Mansur M; Brito DM; García E; Di Salvo HE; Verdini F; Domínguez C; Jorda-Vargas L; Roberti J; Di Girolamo G; Estrada E
    Emerg Med J; 2022 Feb; 39(2):88-93. PubMed ID: 34907003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperbaric oxygen therapy for long COVID (HOT-LoCO), an interim safety report from a randomised controlled trial.
    Kjellberg A; Hassler A; Boström E; El Gharbi S; Al-Ezerjawi S; Kowalski J; Rodriguez-Wallberg KA; Bruchfeld J; Ståhlberg M; Nygren-Bonnier M; Runold M; Lindholm P
    BMC Infect Dis; 2023 Jan; 23(1):33. PubMed ID: 36670365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dutch multicentre, prospective follow-up, cohort study comparing the neurological and neuropsychological sequelae of hospitalised non-ICU- and ICU-treated COVID-19 survivors: a study protocol.
    Klinkhammer S; Horn J; Visser-Meilij JMA; Verwijk E; Duits A; Slooter AJC; van Heugten CM;
    BMJ Open; 2021 Oct; 11(10):e054901. PubMed ID: 34620676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validating a clinical laboratory parameter-based deisolation algorithm for patients with COVID-19 in the intensive care unit using viability PCR: the CoLaIC multicentre cohort study protocol.
    Schoenmakers T; van Bussel BCT; Gorissen SHM; van Loo IHM; van Rosmalen F; Verboeket-van de Venne WPHG; Wolffs PFG; van Mook WNKA; Leers MPG; ;
    BMJ Open; 2023 Feb; 13(2):e069455. PubMed ID: 36854586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.